Literature DB >> 26416261

Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.

Dario I Carrasco1, Kevin L Seburn2, Martin J Pinter3.   

Abstract

In mice that express SOD1 mutations found in human motor neuron disease, degeneration begins in the periphery for reasons that remain unknown. At the neuromuscular junction (NMJ), terminal Schwann cells (TSCs) have an intimate relationship with motor terminals and are believed to help maintain the integrity of the motor terminal. Recent evidence indicates that TSCs in some SOD1 mice exhibit abnormal functional properties, but other aspects of possible TSC involvement remain unknown. In this study, an analysis of TSC morphology and number was performed in relation to NMJ innervation status in mice which express the G93A SOD1 mutation. At P30, all NMJs of the fast medial gastrocnemius (MG) muscle were fully innervated by a single motor axon but 50% of NMJs lacked TSC cell bodies and were instead covered by the processes of Schwann cells with cell bodies located on the preterminal axons. NMJs in P30 slow soleus muscles were also fully innervated by single motor axons and only 5% of NMJs lacked a TSC cell body. At P60, about 25% of MG NMJs were denervated and lacked labeling for TSCs while about 60% of innervated NMJs lacked TSC cell bodies. In contrast, 96% of P60 soleus NMJs were innervated while 9% of innervated NMJs lacked TSC cell bodies. The pattern of TSC abnormalities found at P30 thus correlates with the pattern of denervation found at P60. Evidence from mice that express the G85R SOD1 mutation indicate that TSC abnormalities are not unique for mice that express G93A SOD1 mutations. These results add to an emerging understanding that TSCs may play a role in motor terminal degeneration and denervation in animal models of motor neuron disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Denervation; Motor neuron disease; Motor terminal; Neurodegeneration; Neuromuscular junction; Terminal Schwann cell

Mesh:

Substances:

Year:  2015        PMID: 26416261      PMCID: PMC4768763          DOI: 10.1016/j.expneurol.2015.09.014

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  49 in total

Review 1.  Ion channel redistribution and function during development of the myelinated axon.

Authors:  I Vabnick; P Shrager
Journal:  J Neurobiol       Date:  1998-10

Review 2.  Schwann cells induce and guide sprouting and reinnervation of neuromuscular junctions.

Authors:  Y J Son; J T Trachtenberg; W J Thompson
Journal:  Trends Neurosci       Date:  1996-07       Impact factor: 13.837

3.  ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions.

Authors:  L I Bruijn; M W Becher; M K Lee; K L Anderson; N A Jenkins; N G Copeland; S S Sisodia; J D Rothstein; D R Borchelt; D L Price; D W Cleveland
Journal:  Neuron       Date:  1997-02       Impact factor: 17.173

4.  Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model.

Authors:  Danielle Arbour; Elsa Tremblay; Éric Martineau; Jean-Pierre Julien; Richard Robitaille
Journal:  J Neurosci       Date:  2015-01-14       Impact factor: 6.167

5.  Sodium channel distribution in axons of hypomyelinated and MAG null mutant mice.

Authors:  I Vabnick; A Messing; S Y Chiu; S R Levinson; M Schachner; J Roder; C Li; S Novakovic; P Shrager
Journal:  J Neurosci Res       Date:  1997-10-15       Impact factor: 4.164

6.  Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice.

Authors:  Margaret Wong; Lee J Martin
Journal:  Hum Mol Genet       Date:  2010-03-10       Impact factor: 6.150

7.  Dismutase-competent SOD1 mutant accumulation in myelinating Schwann cells is not detrimental to normal or transgenic ALS model mice.

Authors:  Bradley J Turner; Steven Ackerley; Kay E Davies; Kevin Talbot
Journal:  Hum Mol Genet       Date:  2009-12-15       Impact factor: 6.150

8.  Nerve terminal degeneration is independent of muscle fiber genotype in SOD1 mice.

Authors:  Dario I Carrasco; Edyta K Bichler; Kevin L Seburn; Martin J Pinter
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

9.  GAP-43 and p75NGFR immunoreactivity in presynaptic cells following neuromuscular blockade by botulinum toxin in rat.

Authors:  S M Hassan; F G Jennekens; H Veldman; B A Oestreicher
Journal:  J Neurocytol       Date:  1994-06

10.  Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice.

Authors:  Christian S Lobsiger; Severine Boillee; Melissa McAlonis-Downes; Amir M Khan; M Laura Feltri; Koji Yamanaka; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-27       Impact factor: 11.205

View more
  22 in total

Review 1.  New perspectives on amyotrophic lateral sclerosis: the role of glial cells at the neuromuscular junction.

Authors:  Danielle Arbour; Christine Vande Velde; Richard Robitaille
Journal:  J Physiol       Date:  2016-12-01       Impact factor: 5.182

Review 2.  Clinical relevance of terminal Schwann cells: An overlooked component of the neuromuscular junction.

Authors:  Katherine B Santosa; Alexandra M Keane; Albina Jablonka-Shariff; Bianca Vannucci; Alison K Snyder-Warwick
Journal:  J Neurosci Res       Date:  2018-03-13       Impact factor: 4.164

Review 3.  Neuromuscular junction degeneration in muscle wasting.

Authors:  Rüdiger Rudolf; Michael R Deschenes; Marco Sandri
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2016-05       Impact factor: 4.294

4.  Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

Authors:  Dario I Carrasco; Ben A Bahr; Kevin L Seburn; Martin J Pinter
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

Review 5.  Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

Authors:  Sagar Verma; Shiffali Khurana; Abhishek Vats; Bandana Sahu; Nirmal Kumar Ganguly; Pradip Chakraborti; Mandaville Gourie-Devi; Vibha Taneja
Journal:  Mol Neurobiol       Date:  2022-01-08       Impact factor: 5.590

6.  Properties of Glial Cell at the Neuromuscular Junction Are Incompatible with Synaptic Repair in the SOD1G37R ALS Mouse Model.

Authors:  Éric Martineau; Danielle Arbour; Joanne Vallée; Richard Robitaille
Journal:  J Neurosci       Date:  2020-08-28       Impact factor: 6.167

7.  Validation of terminal Schwann cell gene marker expression by fluorescent in situ hybridization using RNAscope.

Authors:  Bonnie L Seaberg; Sohum Purao; Mendell Rimer
Journal:  Neurosci Lett       Date:  2022-01-20       Impact factor: 3.046

Review 8.  Modelling and Refining Neuronal Circuits with Guidance Cues: Involvement of Semaphorins.

Authors:  Greta Limoni
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

Review 9.  Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.

Authors:  Valentina Cappello; Maura Francolini
Journal:  Int J Mol Sci       Date:  2017-10-03       Impact factor: 5.923

10.  Brain injury in combination with tacrolimus promotes the regeneration of injured peripheral nerves.

Authors:  Xin-Ze He; Jian-Jun Ma; Hao-Qi Wang; Tie-Min Hu; Bo Sun; Yun-Feng Gao; Shi-Bo Liu; Wei Wang; Pei Wang
Journal:  Neural Regen Res       Date:  2017-06       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.